Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...

On July 14, 2025 Fresenius filed two IPR petitions challenging Regeneron’s patents related to aflibercept. Regeneron has not asserted that ...

Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin ...

A downtrend has been apparent in Fresenius (FMS) lately. While the stock has lost 9.1% over the past four weeks, it could ...

The Blood Purification Devices Market is expected to grow at a 5.40% CAGR, reaching USD 26.86 billion by 2032. Growth factors include rising kidney disease cases, hypertension, and diabetes. Key ...

Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.

German stocks are down sharply on Friday due to heavy selling across the board amid rising trade tensions following U.S. President Donald Trump announcing sharply higher tariffs ...

Ltd., widely known as Baurs, a leading conglomerate with diversified business interests in Sri Lanka and a pioneer and ...

The company continues to strive toward higher margins, which may help earnings grow faster than sales, on a durable basis, especially if its new CEO introduces some of his former employer's (Danaher's ...

Eurozone inflation and US Jobs Report in focus. Market outlook hinges on soft data to revive dovish bets and lift the DAX ...

Researchers at the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ OT) of the University Medical Center Göttingen (UMG) have ...